Justification for valsartan and telmisartan prescribing to patients with coronary artery disease and diabetes melitus type 2

Abstract

Introduction: It is known that there is a need to prescribe blood pressure control drugs to patients with coronary artery disease (CAD). Among them there is the reninangiotensin-aldosterone system blockers group (ARBs). There is evidence that the designation of ARBs improves predictions of the progress of CAD.